Allergan PLC said Monday that Chief Financial Officer Tessa Hilado will retire, effective when a successor is named. Hilado joined Allergan in December 2014. “When I joined Allergan in December 2014, I promised Brent Saunders, Chairman and CEO, that I would stay three years to help transform the finance organization, institute better systems and financial controls and improve the balance sheet,” Hilado said. “Now is a good time to announce my retirement from Allergan so that we have time to identify my successor and orchestrate a smooth hand-off to continue Allergan’s progress.” Earlier, Allergan announced a new $2 billion stock repurchase program. The stock has lost 20.5% since the end of 2014, while the SPDR S&P Pharmaceuticals ETF has shed 20.0% and the S&P 500 has climbed 21.5%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News